Samit Hirawat, M.D., is a distinguished medical professional currently serving as the Executive Vice President, Chief Medical Officer, and Head of Development at Bristol Myers Squibb, a leading global biopharmaceutical company. Dr. Hirawat joined Bristol Myers Squibb in 2019, bringing with him a wealth of experience in clinical development and medical affairs. His role at the company involves overseeing the entire development pipeline, from early-stage research to late-stage clinical trials, ensuring that innovative therapies reach patients efficiently and safely. Prior to joining Bristol Myers Squibb, Dr. Hirawat held several key positions in the pharmaceutical industry. He spent over a decade at Sanofi, where he served as the Senior Vice President and Head of Global Oncology Development. During his tenure at Sanofi, he played a pivotal role in advancing the oncology portfolio, contributing to the development and approval of several groundbreaking cancer treatments. Dr. Hirawat's expertise in oncology and his strategic leadership have been instrumental in driving forward the scientific and clinical agendas of the companies he has worked with. Dr. Hirawat's academic background is equally impressive. He earned his medical degree from the University of Mumbai and completed his residency in internal medicine at the University of Medicine and Dentistry of New Jersey. He furthered his training with a fellowship in hematology and oncology at the University of Pennsylvania. His commitment to advancing medical science is evident in his numerous publications and presentations at international conferences. At Bristol Myers Squibb, Dr. Hirawat continues to lead with a patient-centric approach, focusing on accelerating the development of transformative medicines across various therapeutic areas.